Thu, September 16, 2010
[ Thu, Sep 16th 2010 ] - Market Wire
Osiris Therapeutics to Present at UBS Global Life Sciences Conference
[ Thu, Sep 16th 2010 ] - Market Wire
Community Health Systems Announces New 4 Million Share Open Market Share Repurchase
[ Thu, Sep 16th 2010 ] - Market Wire
Aetna Signs Contract Extension with University of Pennsylvania Health System
[ Thu, Sep 16th 2010 ] - Market Wire
CYTOGENIX, INC. Schedules Shareholder's Conference Call on September 22nd
[ Thu, Sep 16th 2010 ] - Market Wire
Abiomed Showcases Impella® Technology at TCT 201 .. eakfast Series Featuring USpella and Case Reviews
[ Thu, Sep 16th 2010 ] - Market Wire
Healthways Announces Achievements in Medicare Health Support; Other Seniorsa? Programs
[ Thu, Sep 16th 2010 ] - Market Wire
Medtronic Receives European CE Mark Approval for .. Brain Stimulation Therapy for Refractory Epilepsy
[ Thu, Sep 16th 2010 ] - Market Wire
Cellular Dynamics International, ACEA Biosciences .. Cooperate to Evaluate iCell Cardiomyocytes on the
[ Thu, Sep 16th 2010 ] - Market Wire
NPS Pharmaceuticals Announces Pricing of Public Offering of Common Stock
[ Thu, Sep 16th 2010 ] - Market Wire
ImmunoCellular Therapeutics Selects Averion Inter .. onal Corp. to Conduct Phase II Glioblastoma Study
[ Thu, Sep 16th 2010 ] - Market Wire
Akorn Announces Launch of Erythromycin Ophthalmic Ointment USP 1 g
[ Thu, Sep 16th 2010 ] - Market Wire
GTx Announces Corporate Presentation at the UBS Global Life Sciences Conference
[ Thu, Sep 16th 2010 ] - Market Wire
Alkermes Stock Trading Halted Today
[ Thu, Sep 16th 2010 ] - Market Wire
BioCryst Reports Positive Results From A Phase 2 .. 8 Combined with Allopurinol in Patients with Gout
Wed, September 15, 2010
[ Wed, Sep 15th 2010 ] - Market Wire
Gileads HIV-Einzeltablette, das aQuada-Prparat, z .. 8-wchiger Phase-II-Studie hohe virale Suppression
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien maakt hoogtepunten beleggersvergadering bekend
[ Wed, Sep 15th 2010 ] - Market Wire
Qtrax Beta Available in India
[ Wed, Sep 15th 2010 ] - Market Wire
Covidien Anuncia Destaques da Assembl©ia de Investidores
[ Wed, Sep 15th 2010 ] - Market Wire
Forest Laboratories, Inc. Finalizes Previously Di .. vernment Investigations and Related Civil Qui Tam
[ Wed, Sep 15th 2010 ] - Market Wire
Crozer-Keystone Health System Joins Aetna Better Health Network
[ Wed, Sep 15th 2010 ] - Market Wire
Bond Labs Expands Resurrection(TM) into the Atlanta and Savannah Markets
[ Wed, Sep 15th 2010 ] - Market Wire
BioCryst to Present Peramivir Data at the 50th Annual ICAAC Meeting
[ Wed, Sep 15th 2010 ] - Market Wire
Celgene Corporation to Present at the UBS 2010 Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
Medical Action Industries to Present in the 2010 UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
ArthroCare to Present at UBS Global Life Sciences Conference
[ Wed, Sep 15th 2010 ] - Market Wire
BioCryst Reports Results from Two Forodesine Oncology Studies
[ Wed, Sep 15th 2010 ] - Market Wire
SuperGen to Present at UBS Global Life Sciences Conference on September 22nd
[ Wed, Sep 15th 2010 ] - Market Wire
Four Rivers Announces Licensure of STT Technology .. Gain, Reduction of Overhead Costs and Future Prof
Tue, September 14, 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. n On Behalf of Shareholders of ZymoGenetics, Inc.
[ Tue, Sep 14th 2010 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. entation at Stifel Nicolaus Healthcare Conference
[ Tue, Sep 14th 2010 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Inves .. Fiduciary Duties by the Officers and Directors of
[ Tue, Sep 14th 2010 ] - Market Wire
Alexion to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Alkermes Announces Posting of Briefing Documents .. ttee Meeting for VIVITROL® for Opioid Dependence
[ Tue, Sep 14th 2010 ] - Market Wire
Guided Therapeutics Completes $3 Million Financing
[ Tue, Sep 14th 2010 ] - Market Wire
Somaxon Pharmaceuticals to Present at the UBS Global Life Sciences Conference
[ Tue, Sep 14th 2010 ] - Market Wire
Derma Sciences to Complete Enrollment in DSC127 Phase 2 Wound Healing Trial This Month
[ Tue, Sep 14th 2010 ] - Market Wire
Synergy Pharmaceuticals to Present at Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
Vortrag von Synergy Pharmaceuticals auf dem Roche Colorado Corporation Peptide Symposium 2010
[ Tue, Sep 14th 2010 ] - Market Wire
CENTRIC HEALTH APPOINTS DR. PAUL GAMBLE TO BOARD OF DIRECTORS
[ Tue, Sep 14th 2010 ] - Market Wire
AngioDynamics Strengthens Executive Team with Key Appointments
[ Tue, Sep 14th 2010 ] - Market Wire
Inspire Announces Webcasts of Presentations at th .. nference and the JMP Securities Healthcare Confer
Mon, September 13, 2010
[ Mon, Sep 13th 2010 ] - Market Wire
Il regime quadruplo a monosomministrazione giorna .. 'HIV di Gilead consente il mantenimento di una so
[ Mon, Sep 13th 2010 ] - Market Wire
A New Audio Interview Featuring Frank Mir, Director of Suffer Apparel, is Now at SmallCapVoice.com
[ Mon, Sep 13th 2010 ] - Market Wire
Allos Therapeutics to Present at Upcoming Investor Conferences
[ Mon, Sep 13th 2010 ] - Market Wire
Biomagnetics Moves Zhuhai Oil Energy Acquisition .. t Phase - Expects Closing During CEO Trip to Chin
[ Mon, Sep 13th 2010 ] - Market Wire
PerkinElmer to Present at UBS Global Life Science Conference
[ Mon, Sep 13th 2010 ] - Market Wire
ARIAD Announces Initiation of Ponatinib (AP24534) .. -Resistant or Intolerant Chronic Myeloid Leukemia
[ Mon, Sep 13th 2010 ] - Market Wire
Pro-Pharmaceuticals Collaborates with Numoda to M .. l Trial to Increase Speed-to-Market for DAVANAT®
[ Mon, Sep 13th 2010 ] - Market Wire
Geron Obtains Exclusive License for Deriving Cart .. Embryonic Stem Cells from University of Edinburgh
[ Mon, Sep 13th 2010 ] - Market Wire
Forest Responds to FDA Complete Response Letter for Roflumilast
[ Mon, Sep 13th 2010 ] - Market Wire
UnitedHealth Group Named to Dow Jones Sustainabil .. erica and World Indices for 12th Consecutive Year
[ Mon, Sep 13th 2010 ] - Market Wire
XenoPort Announces Plans for Phase 3 Development of Arbaclofen Placarbil for Spasticity
[ Mon, Sep 13th 2010 ] - Market Wire
LabCorp Enters into Definitive Agreement to Acquire Genzyme Genetics
[ Mon, Sep 13th 2010 ] - Market Wire
Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference
Sun, September 12, 2010
[ Sun, Sep 12th 2010 ] - Market Wire
Santarus Adds Two Novel Biologic Drug Candidates to Pipeline
Fri, September 10, 2010
[ Fri, Sep 10th 2010 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. Discuss Top-line Data from Lintuzumab (SGN-33) Ph
[ Fri, Sep 10th 2010 ] - Market Wire
ISS Recommends That Response Genetics Shareholder .. Gold Proxy Card to Re-Elect Experienced Directors
[ Fri, Sep 10th 2010 ] - Market Wire
Fitch Affirms CareFusion Corporation's Ratings at 'BBB'; Outlook Stable
[ Fri, Sep 10th 2010 ] - Market Wire
Advanced Cell Technology to Present at the 12th A .. ual Rodman & Renshaw Global Investment Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Orthovita to Present at the UBS Global Life Sciences Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Medtronic Releases 2010 Corporate Citizenship Report
[ Fri, Sep 10th 2010 ] - Market Wire
Teva to Present at the Morgan Stanley Global Healthcare Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Cubist Pharmaceuticalsa? Antibiotic Programs Featured in 47 Presentations at 50th ICAAC
[ Fri, Sep 10th 2010 ] - Market Wire
ArQule, Inc. to Present at Stifel Nicolaus and UBS Conferences
[ Fri, Sep 10th 2010 ] - Market Wire
PerkinElmer to Present at Stifel Nicolaus Healthcare Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Orthofix International to Participate inStifel Nicolaus 2010 Healthcare Conference
[ Fri, Sep 10th 2010 ] - Market Wire
Pro-Pharmaceuticalsa? Presentation at Rodman and .. l Global Investment Conference to Be Webcast Live
[ Fri, Sep 10th 2010 ] - Market Wire
Bioniche Reports Fiscal 2010 Year-End Results
Thu, September 9, 2010
[ Thu, Sep 09th 2010 ] - Market Wire
Amedisys to Present at Two Upcoming Conferences
[ Thu, Sep 09th 2010 ] - Market Wire
Tenet Management to Speak at the Morgan Stanley Global Healthcare Conference on September 14, 2010
[ Thu, Sep 09th 2010 ] - Market Wire
Cohen Milstein Sellers & Toll PLLC Announces Class Action Lawsuit against Almost Family, Inc.
[ Thu, Sep 09th 2010 ] - Market Wire
Helicos BioSciences Files Patent Infringement Lawsuit Against Pacific Biosciences
[ Thu, Sep 09th 2010 ] - Market Wire
Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET
[ Thu, Sep 09th 2010 ] - Market Wire
CIGNA Announces Appearance at the Morgan Stanley Global Healthcare Conference
[ Thu, Sep 09th 2010 ] - Market Wire
Elan Statement Regarding Shareholder Call
[ Thu, Sep 09th 2010 ] - Market Wire
Media Advisory - Oncolytics Biotech(R) Inc. to Pr .. an &; Renshaw Annual Global Investment Conference
[ Thu, Sep 09th 2010 ] - Market Wire
AngioDynamics to Participate At Upcoming Investor Conferences
[ Thu, Sep 09th 2010 ] - Market Wire
CombinatoRx Changes Company Name to Zalicus Inc.
[ Thu, Sep 09th 2010 ] - Market Wire
Salix Pharmaceuticals to Present at Stifel Nicolaus Conference
[ Thu, Sep 09th 2010 ] - Market Wire
Schiff Nutrition International, Inc. to Present a .. ing's 8th Best Ideas Conference on September 16th
[ Thu, Sep 09th 2010 ] - Market Wire
Schiff Nutrition International, Inc. Announces Timing of Fiscal 2011 First Quarter Results
Wed, September 8, 2010
[ Wed, Sep 08th 2010 ] - Market Wire
YM BioSciences announces positive results from CY .. se I study published in British Journal of Cancer
[ Wed, Sep 08th 2010 ] - Market Wire
Hi-Tech Pharmacal Reports Sales of $40.4 Million .. EPS of $0.67 for the Quarter Ended July 31, 2010
[ Wed, Sep 08th 2010 ] - Market Wire
Inspire Announces Webcast of Presentation at Stifel Nicolaus Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
The Shuman Law Firm Announces the Filing of a Cla .. on Lawsuit Against SciClone Pharmaceuticals, Inc.
[ Wed, Sep 08th 2010 ] - Market Wire
LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
Kindred Healthcare to Participate in the Stifel Nicolaus 2010 Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
AngioDynamics Reports Preliminary Fiscal 2011 First Quarter Results
[ Wed, Sep 08th 2010 ] - Market Wire
FDA Advisory Committee Recommends Approval of For .. e Fosamil for the Treatment of Community Acquired
[ Wed, Sep 08th 2010 ] - Market Wire
AGA Medical to Present at the Baird 2010 Health Care Conference
[ Wed, Sep 08th 2010 ] - Market Wire
PPD Establishes Network of Sites for Conducting Phase I Trials in Patients
[ Wed, Sep 08th 2010 ] - Market Wire
Health Management Associates, Inc. to Present at the Morgan Stanley Global Healthcare Conference
[ Wed, Sep 08th 2010 ] - Market Wire
65% of People Whose Prior Treatment for Hepatitis .. SVR (Viral Cure) with Telaprevir-Based Therapy in
[ Wed, Sep 08th 2010 ] - Market Wire
Resurrectiona" Showcased to NYC at the Attica 2 Year Anniversary Party
Tue, September 7, 2010
[ Tue, Sep 07th 2010 ] - Market Wire
Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone® Litigation
[ Tue, Sep 07th 2010 ] - Market Wire
Array BioPharma to Present at the Rodman & Rensha .. nce and the Stifel Nicolaus Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
La Jolla Pharmaceutical Company Provides Update o .. ch for Clinical Products to In-License or Acquire
[ Tue, Sep 07th 2010 ] - Market Wire
Orthofix International to Participate in Morgan Stanley Unplugged Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
BioSante Pharmaceuticals, Inc. to Present at the Rodman & Renshaw Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Health Net Federal Services Meets Target Enrollme .. Chronic Obstructive Pulmonary Disease Management
[ Tue, Sep 07th 2010 ] - Market Wire
CytRx Initiates Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer
[ Tue, Sep 07th 2010 ] - Market Wire
Somaxon Pharmaceuticals Announces Commercial Availability of Silenor
[ Tue, Sep 07th 2010 ] - Market Wire
Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Response Genetics, Inc. to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
[ Tue, Sep 07th 2010 ] - Market Wire
Rosetta Genomics to Present at the Rodman & Renshaw 12th Annual Global Investment Conference
[ Tue, Sep 07th 2010 ] - Market Wire
BioDelivery Sciences Adds New Executive to Lead Business and Strategic Development
[ Tue, Sep 07th 2010 ] - Market Wire
SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference on September 13th
Sat, September 4, 2010
[ Sat, Sep 04th 2010 ] - Market Wire
Herbert A. Fritsche, Ph.D., anteriormente profeso .. on Cancer Center, se incorpora a Health Discovery
[ Sat, Sep 04th 2010 ] - Market Wire
Transdel Pharmaceuticals
[ Sat, Sep 04th 2010 ] - Market Wire
Curis to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
[ Sat, Sep 04th 2010 ] - Market Wire
Wright Medical Group, Inc. to Participate in Upcoming September 2010 Healthcare Conferences
[ Sat, Sep 04th 2010 ] - Market Wire
Aetna Reminds Members Affected by Hurricane Earl Where to Call for Help
[ Sat, Sep 04th 2010 ] - Market Wire
Herbert A. Fritsche, Ph.D., ehemaliger Professor .. nderson Cancer Center tritt Health Discovery Corp
[ Sat, Sep 04th 2010 ] - Market Wire
UnitedHealth Group to Support Members Affected by Hurricane Earl
Fri, September 3, 2010
[ Fri, Sep 03rd 2010 ] - Market Wire
Herbert A. Fritsche, Ph.D., cientista e antigo pr .. o do Anderson Cancer Center, junta-se a Health Di
[ Fri, Sep 03rd 2010 ] - Market Wire
Gilead Sciences presenta alla?Agenzia Europea per .. torizzazione per la?immissione in commercio delle
[ Fri, Sep 03rd 2010 ] - Market Wire
ImmunoCellular Therapeutics Issues Letter to Shareholders
[ Fri, Sep 03rd 2010 ] - Market Wire
Life Technologies to Present at the UBS Global Life Sciences Conference
[ Fri, Sep 03rd 2010 ] - Market Wire
American Learning Corporation to Appeal Nasdaq Delisting Notice
[ Fri, Sep 03rd 2010 ] - Market Wire
KCI?????LifeCella" ???Novadaq Technologies????????????SPY®????????????
[ Fri, Sep 03rd 2010 ] - Market Wire
/C O R R E C T I O N - Mindray Medical International Limited /
[ Fri, Sep 03rd 2010 ] - Market Wire
MDS to Release Third Quarter 2010 Financial Results
[ Fri, Sep 03rd 2010 ] - Market Wire
Tibotec Pharmaceuticals Seeks European Marketing .. r Investigational Once-Daily HIV Treatment TMC278
[ Fri, Sep 03rd 2010 ] - Market Wire
Medisafe 1 Technologies Clarifies the PR Issued o .. ividend, as a Forward Split of 5-1 in the Form of
[ Fri, Sep 03rd 2010 ] - Market Wire
Gilead Sciences Submits European Marketing Applic .. blet Regimen of Truvada® and TMC278 for the Trea
[ Fri, Sep 03rd 2010 ] - Market Wire
Alcon Launches AcrySof® IQ ReSTOR® Toric Intraocular Lens Outside the United States
[ Fri, Sep 03rd 2010 ] - Market Wire
Gilead Sciences dient aanvraag in voor Europese m .. van ©©n tablet per dag van Truvada en TMC278 t
Thu, September 2, 2010
[ Thu, Sep 02nd 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Allergan, Inc.
[ Thu, Sep 02nd 2010 ] - Market Wire
BRINAVESSa" (vernakalant) per infusione approvato .. conversione rapida della fibrillazione atriale di
[ Thu, Sep 02nd 2010 ] - Market Wire
BioDelivery Sciences Announces Positive Meeting w .. eamlined ONSOLIS REMS with Broadened Distribution
[ Thu, Sep 02nd 2010 ] - Market Wire
KCIa?s LifeCell Corporation en Novadaq Technologi .. verkoop- en marketingovereenkomst voor exclusieve
[ Thu, Sep 02nd 2010 ] - Market Wire
Cardiome Achieves $30 Million Milestone
[ Thu, Sep 02nd 2010 ] - Market Wire
Oncolytics Biotech(R) Inc. Announces Randomized P .. to be Conducted by the Gynecologic Oncology Group
[ Thu, Sep 02nd 2010 ] - Market Wire
Rosetta Genomics to Host Second Quarter 2010 Conference Call on Wednesday, September 8, 2010
[ Thu, Sep 02nd 2010 ] - Market Wire
MedPro Safety Products Completes Royalty Monetization Transaction
[ Thu, Sep 02nd 2010 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September
[ Thu, Sep 02nd 2010 ] - Market Wire
AVEO Pharmaceuticals, Inc. to Present at Several Upcoming Investment Conferences
[ Thu, Sep 02nd 2010 ] - Market Wire
Gilead geeft update over aandelenterugkoop van 5 miljard dollar
[ Thu, Sep 02nd 2010 ] - Market Wire
Transdel Pharmaceuticals Presents Phase 3 Study D .. sdel® at World Pain Congress in Montreal, Canada
[ Thu, Sep 02nd 2010 ] - Market Wire
La divisione di KCI LifeCella" Corporation e Nova .. contratto di vendita e marketing per la distribu
Wed, September 1, 2010
[ Wed, Sep 01st 2010 ] - Market Wire
Gilead presenta ltimos datos sobre programa de recompra de acciones por valor de $5.000 millones
[ Wed, Sep 01st 2010 ] - Market Wire
Health Net Strives to Exceed $75,000 Goal Through Annual Golf Classic Despite Hard Economic Times
[ Wed, Sep 01st 2010 ] - Market Wire
Navigant Capital Advisors, LLC Serves as Financia .. Health Systems, Inc. in Its $156.8 Million Sale t
[ Wed, Sep 01st 2010 ] - Market Wire
Amerigroup Launches 24/7 Nurse Pilot Program: A First for Tennessee
[ Wed, Sep 01st 2010 ] - Market Wire
Amerigroup Launches 24/7 Nurse Pilot Program: A First for Maryland
[ Wed, Sep 01st 2010 ] - Market Wire
Inhibitex Successfully Completes Phase 1a Trial of INX-189
[ Wed, Sep 01st 2010 ] - Market Wire
Covidien Announces Investor Meeting Agenda
[ Wed, Sep 01st 2010 ] - Market Wire
Covidien annuncia il programma della riunione degli investitori
[ Wed, Sep 01st 2010 ] - Market Wire
Covidien gibt Tagesordnung seiner Investorenversammlung bekannt
[ Wed, Sep 01st 2010 ] - Market Wire
Covidien divulga programa da reunio com investidores
[ Wed, Sep 01st 2010 ] - Market Wire
Archimedes Pharma Receives European Marketing Aut .. (R) for the Treatment of Breakthrough Cancer Pain
[ Wed, Sep 01st 2010 ] - Market Wire
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
[ Wed, Sep 01st 2010 ] - Market Wire
Emergent BioSolutions Awarded NIAID Contract That .. to Over $58 Million for Advanced Development of T
Tue, August 31, 2010
[ Tue, Aug 31st 2010 ] - Market Wire
Proskauer Represents Sumner Regional Health Syste .. in Its $156.8 Million Sale to LifePoint Hospitals
[ Tue, Aug 31st 2010 ] - Market Wire
New 2010 ESC Guidelines for Percutaneous Coronary .. rtance of FFR in Treatment of Coronary Artery Dis
[ Tue, Aug 31st 2010 ] - Market Wire
Allergan, Inc. Receives FDA Approval for LUMIGANÂ .. Indicated for the Reduction of Elevated Intraocul
[ Tue, Aug 31st 2010 ] - Market Wire
Teleflex to Present at the Stifel Nicolaus 2010 Healthcare Conference
[ Tue, Aug 31st 2010 ] - Market Wire
Quidel Announces FDA Clearance of Its RapidVue® hCG Pregnancy Lateral Flow Diagnostic Test
[ Tue, Aug 31st 2010 ] - Market Wire
Tenet Announces Completion of Cash Tender Offer for 7.375% Senior Notes due 2013
[ Tue, Aug 31st 2010 ] - Market Wire
Humana Awarded Contracts for Puerto Rico Medicaid Program
[ Tue, Aug 31st 2010 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation on Behalf of Shareholders of Genzyme Corporation
[ Tue, Aug 31st 2010 ] - Market Wire
PacificHealth Laboratories Promotes Fred Duffner, Current President, to CEO and President
[ Tue, Aug 31st 2010 ] - Market Wire
Progenics Pharmaceuticals to Present Preclinical .. nal Antibodies Against C. difficile at 2010 ICAAC
[ Tue, Aug 31st 2010 ] - Market Wire
American CareSource Holdings Adds Benefit Administrative Systems to Client Portfolio
[ Tue, Aug 31st 2010 ] - Market Wire
Orthofix International Establishes New $300 Million Credit Facility
[ Tue, Aug 31st 2010 ] - Market Wire
Affymax® Announces Upcoming Webcasts and Conference Participation
Mon, August 30, 2010
[ Mon, Aug 30th 2010 ] - Market Wire
RehabCare to Present at the Stifel Nicolaus Healthcare Conference 2010
[ Mon, Aug 30th 2010 ] - Market Wire
Elan Corporation plc Announces Commencement of As .. to $186,000,000 of 8 7/8% Senior Fixed Rate Note
[ Mon, Aug 30th 2010 ] - Market Wire
Teleflex to Present at the Morgan Stanley Global Healthcare Conference
[ Mon, Aug 30th 2010 ] - Market Wire
Pre and Post-Operative Use of Caldolor® (Ibuprof .. duces Pain and Opioid Use in Newly Published Stud
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien voltooit verkoop van productlijn voor slaaptherapie
[ Mon, Aug 30th 2010 ] - Market Wire
Biomagnetics Announces LOI to Acquire Lanzhou New .. TD Fourth Chinese Asset Targeted at $1.50 BMGP Sh
[ Mon, Aug 30th 2010 ] - Market Wire
BEMA Buprenorphine Phase 2 Study Results Selected for Presentation at Pain Week 2010
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien Completes Sale of Sleep Therapy Product Line
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien perfeziona la vendita della linea di prodotti per la terapia del sonno
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien cl'ture la vente de sa ligne de produits de th©rapie du sommeil
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien schliet Verkauf der Produktlinie fr Schlaftherapien ab
[ Mon, Aug 30th 2010 ] - Market Wire
Covidien Completes Sale of Specialty Chemicals Business
[ Mon, Aug 30th 2010 ] - Market Wire
PURATEIN(R) AND SUPERTEIN(TM) GRAS NOTIFIED - U.S .. ISSUES NO OBJECTION LETTER ON GRAS STATUS OF PUR
Sun, August 29, 2010
[ Sun, Aug 29th 2010 ] - Market Wire
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
Fri, August 27, 2010
[ Fri, Aug 27th 2010 ] - Market Wire
Aetna Completes $750 Million, 10-Year Bond Offering
[ Fri, Aug 27th 2010 ] - Market Wire
Medical Action Industries Inc. Completes Acquisition of AVID Medical, Inc.
[ Fri, Aug 27th 2010 ] - Market Wire
Zynex Announces New ChiefFinancial Officer
[ Fri, Aug 27th 2010 ] - Market Wire
Experienced Financial Executive, Peter Donato, Joins Hythiam as CFO
[ Fri, Aug 27th 2010 ] - Market Wire
?????????????????????
[ Fri, Aug 27th 2010 ] - Market Wire
HealthSpring, Inc. to Acquire Bravo Health, Inc.
[ Fri, Aug 27th 2010 ] - Market Wire
Genentech Receives Refuse to File Letter from FDA for T-DM1
Thu, August 26, 2010
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis completa la compra a Nestl© de intereses mayoritarios en Alcon
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis erwirbt Aktienmehrheit an Alcon von Nestl©
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis conclui compra de participao majoritria da Nestl© na Alcon
[ Thu, Aug 26th 2010 ] - Market Wire
RehabCare to Present at the Morgan Stanley Global Healthcare Conference
[ Thu, Aug 26th 2010 ] - Market Wire
Spectral Molecular Imaging, Inc. Announces Accele .. its Early Melanoma Detection Product SkinSpecta"
[ Thu, Aug 26th 2010 ] - Market Wire
Health Net, Inc. Mourns the Death of Thomas T. Farley, a Member of Its Board of Directors
[ Thu, Aug 26th 2010 ] - Market Wire
American HomePatient Announces Five Business Day .. lf-Tender Offer and Modification of 90% Condition
[ Thu, Aug 26th 2010 ] - Market Wire
Medtronic reoit de Sant© Canada la?homologation .. ?ablation de la fibrillation auriculaire par radi
[ Thu, Aug 26th 2010 ] - Market Wire
Medtronic Receives Health Canada Approval for the .. ofrequency Ablation Tools for Atrial Fibrillation
[ Thu, Aug 26th 2010 ] - Market Wire
International Stem Cell Corporation Not Adversely Affected by Stem Cell Research Funding Ban
[ Thu, Aug 26th 2010 ] - Market Wire
Celgene Corporation Announces Appointment of Jacq .. Senior Vice President and Chief Financial Officer
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis voltooit aankoop meerderheidsbelang Alcon van Nestl©
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis completa acquisto da Nestl© di interesse di maggioranza su Alcon

BioCryst to Host & Webcast Investor Day on September 16, 2010


//health-fitness.news-articles.net/content/2010/ .. t-webcast-investor-day-on-september-16-2010.html
Published in Health and Fitness on Wednesday, September 8th 2010 at 6:52 GMT by Market Wire   Print publication without navigation


BIRMINGHAM, Ala.--([ BUSINESS WIRE ])--BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that it will host and webcast its Investor Day in New York City on Thursday, September 16, 2010 from 9 a.m. to 12 p.m. Eastern Time. BioCrysta™s management team will provide a comprehensive overview of BioCrysta™s strategy and clinical programs as well as the Companya™s drug discovery capabilities, financial position and other topics.

Links to a live audio webcast and replay of the presentation may be accessed on the BioCryst Web site at [ www.biocryst.com ].

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BioCryst has progressed two novel compounds that are in late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a purine nucleoside phosphorylase (PNP) inhibitor forcutaneous T-cell lymphoma (CTCL). Additionally, BioCryst has a third product candidate, BCX4208a"a next generation PNP inhibitora"in mid-stage trials for the treatment of gout. Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. For more information please visit BioCrysta™s Web site at [ www.biocryst.com ].

This press release contains forward-looking statements, including statements regarding future results and achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Please refer to the documents BioCryst files periodically with the SEC and located at [ http://investor.shareholder.com/biocryst/sec.cfm ].

BCRXW


Publication Contributing Sources